USPTO serial 99709437
AQUAGEN BIOSOLUTIONS
Status 641Office Action
- Filing date
- Mar 18, 2026
- Status date
- Aug 4, 2026
- Registration date
- —
- Examiner
- HUSSAIN, TASNEEM
Need help with AQUAGEN BIOSOLUTIONS?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: November 4, 2026
Office Action issues
The trademark examiner has refused registration due to a potential likelihood of confusion with an existing registration and requires clarification regarding certain wording in your service description.
Owner
AQUAGEN BIOSOLUTIONS INC.
Harleysville, PA, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific research and development; Scientific research consultancy; Providing scientific research information; Scientific research; Medical research services; Medical research laboratories; Biotechnology research; Research and development in the field of biotechnology; Research and development services in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Biotechnology research in the field of YADA; Biotechnology research in the field of NANOPARTICLES; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Pharmaceutical research and development; Research and development services of new pharmaceutical products; Consulting services in the field of pharmaceutical research and development; Research and development of pharmaceutical preparations for treating malignant tumours; Research and development of new products in the field of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Research and development in the field of pharmaceuticals; Pharmaceutical research and development in the field of mRNA drugs; Research and development services in the field of pharmaceutical preparations; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Aug 4, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 4, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Aug 4, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Aug 4, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Aug 3, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 18, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Mar 18, 2026 | NWAP | NEW APPLICATION ENTERED |